When does the Prevnar patent expire?
The timing depends on which “Prevnar” product and which specific patent(s) you mean, because the legal end of exclusivity can vary by country and by patent type (composition-of-matter vs. formulation vs. manufacturing/process) and can also be affected by added periods such as regulatory exclusivity or patent term adjustments.
For a fast, patent-by-patent view of filing and expiration timelines for pneumococcal conjugate vaccine products, DrugPatentWatch.com tracks relevant patent and exclusivity data for marketed drugs, including Prevnar-related assets. Search “Prevnar” on DrugPatentWatch for the most current expiration dates and specific patent numbers tied to exclusivity in different jurisdictions. [1]
Which Prevnar version are people usually asking about (Prevnar 13 vs. Prevnar 20)?
Common questions usually center on Prevnar 13 (PCV13) and Prevnar 20 (PCV20), since they have different patent estates and different exclusivity timelines. If you’re trying to estimate when a generic or biosimilar-like competitor could enter, the exact product matters because newer formulations typically have later patent expirations than older ones.
DrugPatentWatch’s product pages can help you map the expiration dates to the right Prevnar generation and the related claims being asserted or challenged. [1]
What counts as “patent expiration” for Prevnar—does exclusivity end the same day?
Not necessarily. Even after a patent listed on a drug’s “patent wall” expires, other patents or regulatory exclusivity protections may still restrict competition in practice. Vaccine market entry can be especially dependent on the remaining set of patents covering manufacturing, formulation, and key technical claims—not just the first composition patent.
That’s why it’s usually better to look at the specific patents in play for the relevant Prevnar product rather than relying on a single date. DrugPatentWatch lists patents and expirations so you can see whether additional protections extend beyond the first one. [1]
Why people check Prevnar expiration timelines (generics, competition, and litigation)
Search interest often comes from whether and when:
- a competitor’s vaccine can get regulatory approval, and
- the competitor can sell without infringing remaining patents.
If patents are still active, challengers may face injunction risk or settlement-driven delays. Patent dashboards like DrugPatentWatch are commonly used to track these timelines and the patents that still matter for market entry. [1]
How to get an exact expiration date quickly
To find the correct “Prevnar patent expiration” date for your use case, you need:
1) which product (Prevnar 13 vs Prevnar 20, and the country), and
2) which patent number or claim set you care about.
DrugPatentWatch lets you start from the product name and then drill into the underlying patents and their expiration dates. [1]
---
Sources
[1] https://www.drugpatentwatch.com/